NCT05379673

Brief Summary

In this randomized-controlled trial the investigators will examine the effect of oxygen supplementation on the recovery of breathing for 90 minutes in the immediate post-anesthesia period starting from extubation of the trachea.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
7mo left

Started Oct 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress86%
Oct 2022Dec 2026

First Submitted

Initial submission to the registry

May 12, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 18, 2022

Completed
5 months until next milestone

Study Start

First participant enrolled

October 4, 2022

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

May 16, 2025

Status Verified

May 1, 2025

Enrollment Period

3.7 years

First QC Date

May 12, 2022

Last Update Submit

May 13, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Transcutaneous partial pressure of carbon dioxide (TcPCO2)

    The cumulative segment of time during which the transcutaneous partial pressure of carbon dioxide (TcPCO2: primary outcome) will exceed an upper limit of 45 mmHg (i.e., TcPCO2 \> 45 mmHg)

    Ninety -minute period beginning immediately post-anesthesia.

Secondary Outcomes (1)

  • Apnea / hypopnea index (AHI)

    Ninety -minute period beginning immediately post-anesthesia.

Study Arms (2)

"Conservative O2 Supplementation"

ACTIVE COMPARATOR

Oxygen administration will be titrated to a oxyhemoglobin saturation (SpO2) between 90 and 94%.

Other: Oxygen Gas for Inhalation

"Liberal O2 Supplementation"

EXPERIMENTAL

Oxygen administration will be titrated to an SpO2 \> 96%.

Other: Oxygen Gas for Inhalation

Interventions

Oxyhemoglobin saturation (SpO2) higher than 96% vs SpO2 between 90% and 94%.

"Conservative O2 Supplementation""Liberal O2 Supplementation"

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • American Society of Anesthesiologists (ASA) physical status I-III
  • Body mass index (BMI) less than 40 kg/m2
  • Scheduled to undergo robotic-assisted radical laparoscopic nephrectomy or prostatectomy.

You may not qualify if:

  • Patients with a diagnosis of chronic obstructive pulmonary disorder (COPD), severe neurological, cardiopulmonary, psychiatric, or untreated thyroid disorder
  • Chronic pain condition that is being treated with opioids
  • Patients with a hematocrit lower than 30% at the end of surgery, or those with an excessive blood loss, requiring transfusion of blood products during surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford University School of Medicine

Stanford, California, 94305, United States

RECRUITING

MeSH Terms

Conditions

Respiratory Insufficiency

Interventions

Oxygen

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

ChalcogensElementsInorganic ChemicalsGases

Study Officials

  • Anthony Doufas, MD, PhD

    Professor, Department of Anesthesiology, Stanford University Medical School

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Anthony Doufas, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Patients will be blinded to the received treatment. The investigators, who will monitor the patients and collect the data in the PACU, will be blinded to the primary outcome, but not to the received treatment.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: In the post-anesthesia care unit (PACU), participants will be randomized to receive conservative (titrated to an SpO2 between 90 and 94%) versus liberal (titrated to SpO2 \> 96%) oxygen supplementation, via a non-rebreather mask.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Department of Anesthesiology, Perioperative and Pain Medicine

Study Record Dates

First Submitted

May 12, 2022

First Posted

May 18, 2022

Study Start

October 4, 2022

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

May 16, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations